- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Patent Prosecution, Counseling and IP Due Diligence
News 65 results
Recognition
June 17, 2020
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
Recognition
Recognition
October 9, 2019
Patent Trial and Appeal Board Bar Association Names Lori Gordon to Top 50 Women in PTAB Trials List
Recognition
October 4, 2019
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2019 Guide
Recognition
June 10, 2019
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
Recognition
May 31, 2019
Katie McCarthy Elected President of the New York Intellectual Property Law Association (NYIPLA)
Recognition
Cases & Deals
August 16, 2018
King & Spalding Advises Cancer Prevention Pharmaceuticals on $185 Million Licensing Deal With Mallinckrodt
Recognition
May 18, 2018
Managing IP Names Kathleen McCarthy to Top 250 Women in IP List; Names 13 King & Spalding Lawyers IP Stars
Recognition
May 3, 2018
Chambers USA 2018 Recognizes King & Spalding as a Preeminent U.S. Law Firm
Recognition
May 31, 2017
Chambers USA 2017 Recognizes King & Spalding as a Leading U.S. Law Firm
Recognition
May 25, 2017
New England VC Association Names King & Spalding Transaction Deal of the Year